Premier, Inc.
NASDAQ•PINC
CEO: Mr. Michael J. Alkire
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Listing Date: 2013-09-26
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services for coordinate purchasing decisions, review utilization and achieve and maintain standardization across member's facilities; SaaS informatics products for the purchase additional elements; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
Contact Information
Market Cap
$2.34B
P/E (TTM)
-97.3
48.2
Dividend Yield
3.0%
52W High
$28.79
52W Low
$17.23
52W Range
Rank29Top 17.8%
5.2
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.2 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q1 2026 Data
Revenue
$240.00M-3.28%
4-Quarter Trend
EPS
$0.21-70.42%
4-Quarter Trend
FCF
-$3.57M-107.16%
4-Quarter Trend
2026 Q1 Earnings Highlights
Key Highlights
Merger Agreement Signed Acquisition by Patient Square affiliate agreed for $28.25 cash per share, subject to closing conditions.
IllumiCare Acquisition Complete Preliminary $46.7M purchase price paid for IllumiCare, boosting Performance Services segment operations.
Adjusted EBITDA Declines Total Adjusted EBITDA $54.95M for the quarter, a decrease of $7.48M versus prior year results.
Risk Factors
Merger Closing Contingencies Merger completion relies on stockholder vote and regulatory approvals; timing and success remain uncertain.
Performance Services EBITDA Drop Performance Services Segment Adjusted EBITDA fell 29% to $10.62M due to enterprise license revenue decline.
Operating Cash Flow Weakness Operating cash flow from continuing operations $15.93M, down $64.1M from prior period results.
Outlook
Contigo Business Wind Down Remaining Contigo Health businesses expected to be substantially wound down by December 31, 2025.
GPO Contract Renewal Focus Expect majority of remaining GPO member agreement renewals to be addressed during fiscal year 2026.
Future Intangible Amortization Estimated total amortization expense for intangible assets is $237.69M over the next several fiscal years.
Peer Comparison
Revenue (TTM)
BHC$8.26B
ACHC$3.27B
ADUS$1.35B
Gross Margin (Latest Quarter)
BHC173.2%
ACHC96.4%
GDRX93.2%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| HAE | $3.48B | 20.4 | 19.4% | 50.1% |
| DNLI | $2.81B | -6.2 | -46.3% | 4.2% |
| INSP | $2.73B | 60.7 | 6.7% | 4.0% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-0.0%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow
Research & Insights
Next earnings:Feb 3, 2026
EPS:$0.29
|Revenue:$239.00M
Reports
All Years
Form 10-Q - Q1 2026
Period End: Sep 30, 2025|Filed: Nov 4, 2025|Revenue: $240.00M-3.3%|EPS: $0.21-70.4%MissForm 10-K/A - FY 2025
Period End: Jun 30, 2025|Filed: Oct 24, 2025|Revenue: $1.01B-10.9%|EPS: $0.22-79.0%MissForm 10-K - FY 2025
Period End: Jun 30, 2025|Filed: Aug 19, 2025|Refer to amended dataForm 10-Q - Q3 2025
Period End: Mar 31, 2025|Filed: May 6, 2025|Revenue: $261.38M-8.9%|EPS: $0.31-186.1%MeetForm 10-Q - Q2 2025
Period End: Dec 31, 2024|Filed: Feb 4, 2025|Revenue: $240.27M-28.2%|EPS: $-1.01-324.4%MissForm 10-Q - Q1 2025
Period End: Sep 30, 2024|Filed: Nov 5, 2024|Revenue: $248.14M-22.2%|EPS: $0.71+86.8%BeatForm 10-K - FY 2024
Period End: Jun 30, 2024|Filed: Aug 21, 2024|Revenue: $1.35B+0.8%|EPS: $1.05-28.6%BeatForm 10-Q - Q3 2024
Period End: Mar 31, 2024|Filed: May 7, 2024|Revenue: $286.87M-11.0%|EPS: $-0.36-192.3%Miss